A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo

Edited by Michael Rosenfeld, University of California San Diego, La Jolla, CA; received January 15, 2022; accepted July 21, 2022. August 15, 2022.

Do you trust this headline?

Based on recent headline ratings, 88% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positive.

88%

Media Trust Score88%